325 related articles for article (PubMed ID: 24844163)
1. Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers.
Shrestha N; Shahbazi MA; Araújo F; Zhang H; Mäkilä EM; Kauppila J; Sarmento B; Salonen JJ; Hirvonen JT; Santos HA
Biomaterials; 2014 Aug; 35(25):7172-9. PubMed ID: 24844163
[TBL] [Abstract][Full Text] [Related]
2. The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium.
Araújo F; Shrestha N; Shahbazi MA; Fonte P; Mäkilä EM; Salonen JJ; Hirvonen JT; Granja PL; Santos HA; Sarmento B
Biomaterials; 2014 Nov; 35(33):9199-207. PubMed ID: 25109441
[TBL] [Abstract][Full Text] [Related]
3. Functional hydrophobin-coating of thermally hydrocarbonized porous silicon microparticles.
Bimbo LM; Mäkilä E; Raula J; Laaksonen T; Laaksonen P; Strommer K; Kauppinen EI; Salonen J; Linder MB; Hirvonen J; Santos HA
Biomaterials; 2011 Dec; 32(34):9089-99. PubMed ID: 21864895
[TBL] [Abstract][Full Text] [Related]
4. Cellular interactions of surface modified nanoporous silicon particles.
Bimbo LM; Sarparanta M; Mäkilä E; Laaksonen T; Laaksonen P; Salonen J; Linder MB; Hirvonen J; Airaksinen AJ; Santos HA
Nanoscale; 2012 May; 4(10):3184-92. PubMed ID: 22508528
[TBL] [Abstract][Full Text] [Related]
5. Thiol functionalized polymethacrylic acid-based hydrogel microparticles for oral insulin delivery.
Sajeesh S; Vauthier C; Gueutin C; Ponchel G; Sharma CP
Acta Biomater; 2010 Aug; 6(8):3072-80. PubMed ID: 20144748
[TBL] [Abstract][Full Text] [Related]
6. Facilitated nanoscale delivery of insulin across intestinal membrane models.
Woitiski CB; Sarmento B; Carvalho RA; Neufeld RJ; Veiga F
Int J Pharm; 2011 Jun; 412(1-2):123-31. PubMed ID: 21501675
[TBL] [Abstract][Full Text] [Related]
7. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles.
Li X; Guo S; Zhu C; Zhu Q; Gan Y; Rantanen J; Rahbek UL; Hovgaard L; Yang M
Biomaterials; 2013 Dec; 34(37):9678-87. PubMed ID: 24016855
[TBL] [Abstract][Full Text] [Related]
8. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
9. Mucoadhesive hydrogel microparticles based on poly (methacrylic acid-vinyl pyrrolidone)-chitosan for oral drug delivery.
Sajeesh S; Sharma CP
Drug Deliv; 2011 May; 18(4):227-35. PubMed ID: 21067275
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
Rekha MR; Sharma CP
J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
[TBL] [Abstract][Full Text] [Related]
11. In vitro assessment of biopolymer-modified porous silicon microparticles for wound healing applications.
Mori M; Almeida PV; Cola M; Anselmi G; Mäkilä E; Correia A; Salonen J; Hirvonen J; Caramella C; Santos HA
Eur J Pharm Biopharm; 2014 Nov; 88(3):635-42. PubMed ID: 25305585
[TBL] [Abstract][Full Text] [Related]
12. Surface-functionalized polymethacrylic acid based hydrogel microparticles for oral drug delivery.
Sajeesh S; Bouchemal K; Sharma CP; Vauthier C
Eur J Pharm Biopharm; 2010 Feb; 74(2):209-18. PubMed ID: 19737614
[TBL] [Abstract][Full Text] [Related]
13. Interaction of cruciferin-based nanoparticles with Caco-2 cells and Caco-2/HT29-MTX co-cultures.
Akbari A; Lavasanifar A; Wu J
Acta Biomater; 2017 Dec; 64():249-258. PubMed ID: 29030304
[TBL] [Abstract][Full Text] [Related]
14. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
Jin Y; Song Y; Zhu X; Zhou D; Chen C; Zhang Z; Huang Y
Biomaterials; 2012 Feb; 33(5):1573-82. PubMed ID: 22093292
[TBL] [Abstract][Full Text] [Related]
15. Microfabricated porous silicon particles enhance paracellular delivery of insulin across intestinal Caco-2 cell monolayers.
Foraker AB; Walczak RJ; Cohen MH; Boiarski TA; Grove CF; Swaan PW
Pharm Res; 2003 Jan; 20(1):110-6. PubMed ID: 12608544
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles.
Liu D; Bimbo LM; Mäkilä E; Villanova F; Kaasalainen M; Herranz-Blanco B; Caramella CM; Lehto VP; Salonen J; Herzig KH; Hirvonen J; Santos HA
J Control Release; 2013 Sep; 170(2):268-78. PubMed ID: 23756152
[TBL] [Abstract][Full Text] [Related]
17. Dual chitosan/albumin-coated alginate/dextran sulfate nanoparticles for enhanced oral delivery of insulin.
Lopes M; Shrestha N; Correia A; Shahbazi MA; Sarmento B; Hirvonen J; Veiga F; Seiça R; Ribeiro A; Santos HA
J Control Release; 2016 Jun; 232():29-41. PubMed ID: 27074369
[TBL] [Abstract][Full Text] [Related]
18. Drug permeation across intestinal epithelial cells using porous silicon nanoparticles.
Bimbo LM; Mäkilä E; Laaksonen T; Lehto VP; Salonen J; Hirvonen J; Santos HA
Biomaterials; 2011 Apr; 32(10):2625-33. PubMed ID: 21194747
[TBL] [Abstract][Full Text] [Related]
19. SEDDS for intestinal absorption of insulin: Application of Caco-2 and Caco-2/HT29 co-culture monolayers and intra-jejunal instillation in rats.
Liu J; Werner U; Funke M; Besenius M; Saaby L; Fanø M; Mu H; Müllertz A
Int J Pharm; 2019 Apr; 560():377-384. PubMed ID: 30790612
[TBL] [Abstract][Full Text] [Related]
20. In vitro cytotoxicity of porous silicon microparticles: effect of the particle concentration, surface chemistry and size.
Santos HA; Riikonen J; Salonen J; Mäkilä E; Heikkilä T; Laaksonen T; Peltonen L; Lehto VP; Hirvonen J
Acta Biomater; 2010 Jul; 6(7):2721-31. PubMed ID: 20036766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]